Pneumococcal conjugate second or third-dose vaccines (PCVc) in Marshall Islands
Marshall Islands: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 62.0% in 2025. ▲ Rising
Latest (2025)
62.0%
Change on year
unchanged
World rank
144th
of 194 countries
All-time high
75.0%
in 2015
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Marshall Islands, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Marshall Islands is 62.0%, measured in 2025.
The figure is down 17.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Marshall Islands peaked at 75.0% in 2015 and was at its lowest, 0.0%, in 2008.
That places Marshall Islands 144th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Marshall Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 49.0% | — |
| 2010 | 24.0% | -51.0% |
| 2011 | 35.0% | +45.8% |
| 2012 | 46.0% | +31.4% |
| 2013 | 38.0% | -17.4% |
| 2014 | 29.0% | -23.7% |
| 2015 | 75.0% | +158.6% |
| 2016 | 65.0% | -13.3% |
| 2017 | 72.0% | +10.8% |
| 2018 | 67.0% | -6.9% |
| 2019 | 63.0% | -6.0% |
| 2020 | 38.0% | -39.7% |
| 2021 | 61.0% | +60.5% |
| 2022 | 29.0% | -52.5% |
| 2023 | 62.0% | +113.8% |
| 2024 | 62.0% | +0.0% |
| 2025 | 62.0% | +0.0% |
Marshall Islands compared with similar countries
- Marshall Islands's 62.0% is below the median for upper middle income countries, which is 76.0%, 82% of the median. (57 countries reporting)
- Marshall Islands's 62.0% is below the median for East Asia & Pacific, which is 81.0%, 77% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.5% | 0.0% | 49.0% | 2 |
| 2010s | 51.4% | 24.0% | 75.0% | 10 |
| 2020s | 52.3% | 29.0% | 62.0% | 6 |
Countries ranked near Marshall Islands
- 141 Benin 64.0% compare
- 142 Democratic Republic of Congo 63.0% compare
- 142 Afghanistan 63.0% compare
- 144 Laos 62.0% compare
- 144 Nigeria 62.0% compare
- 147 North Macedonia 60.0% compare
More health data for Marshall Islands
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 3.09 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -7.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0494 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.43 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Marshall Islands?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Marshall Islands was 62.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Marshall Islands?
- The highest recorded value was 75.0% in 2015.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Marshall Islands?
- The lowest recorded value was 0.0% in 2008.
- How does Marshall Islands rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Marshall Islands ranks 144th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Marshall Islands?
- Over the last ten years it is down 17.3%. The long-run trend across the full record is rising.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).